{
  "issued_date": "2014-01-02", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON357135", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2014/001", 
    "Audience": "Healthcare professionals", 
    "Published": "2 January 2014 at 14:00", 
    "Format": "Electronic", 
    "Size": "", 
    "Pages": "5", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "Field Safety Notice", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con325236.pdf", 
      "filename": "downloads/65d8f553b3afa33500d333b94a51e4c17eb4afab/con325236.pdf", 
      "original_filename": "con325236.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FSN dated 3 April 2013", 
      "assetid": 1, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con260325.pdf", 
      "filename": "downloads/b6c7d6f2c9c09f2c2ba541b53554976a240958fe/con260325.pdf", 
      "original_filename": "con260325.pdf"
    }, 
    {
      "content_type": "image/png", 
      "title": "OPTEASE\u00ae retrievable vena cava filter", 
      "assetid": 2, 
      "original_url": "http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/con361808.png", 
      "filename": "downloads/3d883d5964c30c00b81a1cbda5393a88983121ef/con361808.png", 
      "original_filename": "con361808.png"
    }
  ], 
  "body": "## Device\n\n![ASSET_TAG](#ASSET2)OPTEASE\u00ae retrievable vena cava filter, manufactured by Cordis Corporation. Lots with number 15960131 or below.\n\n## Problem\n\nRisk of serious patient injury from the migration of a wrongly orientated inferior vena cava (IVC) filter.\n\nOn 8 October 2013 Cordis Corporation issued an urgent [ASSET_TAG](#ASSET0) (341Kb) recalling 217 distributed lots of the OPTEASE retrievable vena cava filter, due to a printing error in the device labelling. The error involved the access site arrow pointing the wrong way on the storage tube for a filter intended to be placed using the femoral approach, and resulted in the filter being implanted upside down. The filter had to be retrieved percutaneously to remove the risk of it migrating towards the patient\u2019s heart, because the filter\u2019s retaining barbs would have provided no migration resistance. The procedure had to be completed using a jugular approach, contrary to the instructions for use, because the retrieval hook was orientated upwards in the cranial direction.\n\nThe affected OPTEASE filters were manufactured between November 2010 and August 2013. Cordis has confirmed that all unused filters have now been recalled, and that no other instances of incorrect arrow orientation have been found from inspection of over 10,000 storage tubes manufactured at the same time as distributed product. The MHRA is issuing this Medical Device Alert because the manufacturer\u2019s FSN does not have advice on the management of patients already implanted with an OPTEASE IVC filter. Cranial migration of any IVC filter carries a fatal risk to the patient. Although the risk of migration may decrease the longer the implant has been in place as the filter becomes embedded in the caval wall, there are no data to confirm a time at which migration would no longer occur.\n\nCordis Corporation currently manufactures two distinct models of IVC filter:  \n  \n  * The TRAPEASE \u00ae permanent vena cava filter, not designed to be retreived. It has no retrieval hook and has bi-directional retaining barbs. Therefore orientation is not critical.  \n  * The OPTEASE\u00ae retrievable vena cava filter, a temporary filter designed to be retrieved within 12 days (after which it is considered a permanent implant). It has retaining barbs that are uni-directional, and must therefore be implanted in one orientation only (see [ASSET_TAG](#ASSET1) (183Kb)). It incorporates a retrieval hook which should always point in the caudal direction (irrespective of implantation route) to facilitate femoral retrieval, and to ensure that the retaining hooks are securing the filter against migration.  \n  \n## Action\n\nFor all patients implanted with an affected OPTEASE IVC filter:  \n  \n  * Review retained post-op images to check whether the implanted filter is correctly orientated, which is with the retrieval hook in the caudal direction.  \n  * Recall for rescreening all patients for whom correct orientation cannot be confirmed. These patients should be recalled as soon as possible, prioritising those with the most recent implants.  \n  * Weigh the serious risk of filter migration against the risk of a re-intervention for a filter that is implanted upside down. Both risks may vary according to how long the implant has been in place, and should be assessed for each patient individually.  \n  * Be aware that re-intervention, where considered appropriate, should be undertaken as soon as possible, and would require a jugular approach.  \n  * Ensure that all IVC filters are correctly orientated prior to loading into the delivery system and insertion into the patient. Note that the filter\u2019s retaining barbs protect against migration in only one direction.  \n  \n### Action by\n\nClinicians who manage and implant patients with IVC filters.\n\n## Distribution\n\nThis MDA has been sent to:  \n  \n  * Care Quality Commission (CQC) (Headquarters) for information  \n  * HSC trusts in Northern Ireland (Chief Executives)  \n  * NHS boards and trusts in Wales (Chief Executives)  \n  * NHS boards in Scotland (Equipment Coordinators)  \n  * NHS England area teams for information  \n  * NHS trusts in England (Chief Executives)  \n  \n  \n### Onward distribution\n\nPlease bring this notice to the attention of relevant employees in your establishment. Below is a suggested list of recipients.\n\nTrusts  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * Adult intensive care units  \n  * Anti-coagulation nurse specialists  \n  * Cardiac laboratory technicians  \n  * Cardiologists  \n  * Cardiology departments  \n  * Cardiothoracic surgeons  \n  * Clinical governance leads  \n  * Consultant haematologists specialising in thromboprophylaxis  \n  * Coronary care departments  \n  * Intensive care nursing staff (adult)  \n  * Intensive care units  \n  * Medical directors  \n  * Nursing executive directors  \n  * Orthopaedic surgeons  \n  * Purchasing managers  \n  * Radiographer superintendents  \n  * Radiographers  \n  * Radiologists  \n  * Radiology departments  \n  * Radiology directors  \n  * Risk managers  \n  * Supplies departments  \n  * Theatre managers  \n  * Vascular surgeons  \n  \n### Independent distribution\n\nEstablishments registered with the Care Quality Commission (CQC) (England only)  \nThis alert should be read by:  \n  \n  * Hospitals in the independent sector  \n  * Independent treatment centres  \n  * Private medical practitioners  \n  \nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health\u2019s Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk) and requesting this facility.\n\n## Manufacturer Contact\n\nStephanie Armstrong  \nQuality/Regulatory Compliance Associate  \nJohnson & Johnson Medical Limited, Pinewood Campus,  \nNinemile Ride, Wokingham, Berkshire, RG40 3EW  \nTel: 01344 871 103  \nEmail: [sarmstr1@its.jnj.com](mailto:sarmstr1@its.jnj.com)\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk). \n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2014/001 or 2013/010/010/081/003.\n\nTechnical aspects  \nBayode Adisa or Alexander Mclaren  \nMedicines & Healthcare Products Regulatory Agency  \nFloor 4, 151 Buckingham Palace Road  \nLondon\u00a0  \nSW1W 9SZ  \nTel: 020 3080 7223 / 7292\u00a0  \nFax: 020 8754 3965  \nEmail: [bayode.adisa@mhra.gsi.gov.uk](mailto:bayode.adisa@mhra.gsi.gov.uk) or [alexander.mclaren@mhra.gsi.gov.uk](mailto:alexander.mclaren@mhra.gsi.gov.uk)\n\nClinical aspects  \nMedicines & Healthcare Products Regulatory Agency  \nFloor 4, 151 Buckingham Palace Road  \nLondon\u00a0  \nSW1W 9SZ  \nTel: 020 3080 7032 / 7248  \nFax: 020 8754 3965  \nEmail: [kayleigh.purdon@mhra.gsi.gov.uk](mailto:kayleigh.purdon@mhra.gsi.gov.uk) or [carol.lowry@mhra.gsi.gov.uk](mailto:carol.lowry@mhra.gsi.gov.uk)\n\n### How to report adverse incidents\n\nPlease report via our website:\u00a0[Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm)  \nFurther information about CAS can be found\u00a0[on the CAS website](https://www.cas.dh.gov.uk/Home.aspx)\u00a0(external link)\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.  \n  \nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings, Stormont Estate  \nDundonald BT4 3SQ  \nTel: 02890 523 704  \nFax: 02890 523 900  \nEmail:\u00a0[NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n### How to report adverse incidents in Northern Ireland\n\nPlease report directly to NIAIC, further information can be found on the\u00a0[NIAIC website](http://www.dhsspsni.gov.uk/niaic)\u00a0(external link)  \nFurther information about SABS can be found\u00a0[on the SABS website](http://sabs.dhsspsni.gov.uk/)\u00a0(external link)\n\n## Scotland\n\nAll requests regarding return, replacement or modification of the devices mentioned in this alert should be directed to the relevant supplier or manufacturer.  \n  \nOther enquiries and adverse incident reports in Scotland should be addressed to:  \n  \nIncident Reporting and Investigation Centre  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh EH12 9EB  \nTel: 0131 275 7575  \nFax: 0131 314 0722  \nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n[Incident Reporting and Investigation Centre](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) (external link)\n\n## Wales\n\nEnquiries in Wales should be addressed to:  \n  \nImproving Patient Safety Team  \nMedical Directorate  \nWelsh Government  \nCathays Park  \nCardiff CF10 3NQ\n\nTel: 029 2082 5801  \nEmail:\u00a0[Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<img src=\"#ASSET2\" alt=\"ASSET_TAG\"><span>OPTEASE&#174; retrievable vena cava filter, manufactured by Cordis Corporation. Lots with number 15960131 or below.</span>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p><span>Risk of serious patient injury from the migration of a wrongly orientated inferior vena cava (IVC) filter.</span></p>\n\n<p>On 8 October 2013 Cordis Corporation issued an urgent <a href=\"#ASSET0\">ASSET_TAG</a> (341Kb) recalling 217 distributed lots of the OPTEASE retrievable vena cava filter, due to a printing error in the device labelling. The error involved the access site arrow pointing the wrong way on the storage tube for a filter intended to be placed using the femoral approach, and resulted in the filter being implanted upside down. The filter had to be retrieved percutaneously to remove the risk of it migrating towards the patient&#8217;s heart, because the filter&#8217;s retaining barbs would have provided no migration resistance. The procedure had to be completed using a jugular approach, contrary to the instructions for use, because the retrieval hook was orientated upwards in the cranial direction.</p>\n\n<p>The affected OPTEASE filters were manufactured between November 2010 and August 2013. Cordis has confirmed that all unused filters have now been recalled, and that no other instances of incorrect arrow orientation have been found from inspection of over 10,000 storage tubes manufactured at the same time as distributed product. The MHRA is issuing this Medical Device Alert because the manufacturer&#8217;s FSN does not have advice on the management of patients already implanted with an OPTEASE IVC filter. Cranial migration of any IVC filter carries a fatal risk to the patient. Although the risk of migration may decrease the longer the implant has been in place as the filter becomes embedded in the caval wall, there are no data to confirm a time at which migration would no longer occur.</p>\n\n<p>Cordis Corporation currently manufactures two distinct models of IVC filter:</p>\n\n<ul>\n<li>The TRAPEASE &#174; permanent vena cava filter, not designed to be retreived. It has no retrieval hook and has bi-directional retaining barbs. Therefore orientation is not critical.</li>\n\n<li>The OPTEASE&#174; retrievable vena cava filter, a temporary filter designed to be retrieved within 12 days (after which it is considered a permanent implant). It has retaining barbs that are uni-directional, and must therefore be implanted in one orientation only (see <a href=\"#ASSET1\">ASSET_TAG</a> (183Kb)). It incorporates a retrieval hook which should always point in the caudal direction (irrespective of implantation route) to facilitate femoral retrieval, and to ensure that the retaining hooks are securing the filter against migration.</li>\n</ul>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<p>For all patients implanted with an affected OPTEASE IVC filter:</p>\n\n<ul>\n<li>Review retained post-op images to check whether the implanted filter is correctly orientated, which is with the retrieval hook in the caudal direction.</li>\n\n<li>Recall for rescreening all patients for whom correct orientation cannot be confirmed. These patients should be recalled as soon as possible, prioritising those with the most recent implants.</li>\n\n<li>Weigh the serious risk of filter migration against the risk of a re-intervention for a filter that is implanted upside down. Both risks may vary according to how long the implant has been in place, and should be assessed for each patient individually.</li>\n\n<li>Be aware that re-intervention, where considered appropriate, should be undertaken as soon as possible, and would require a jugular approach.</li>\n\n<li>Ensure that all IVC filters are correctly orientated prior to loading into the delivery system and insertion into the patient. Note that the filter&#8217;s retaining barbs protect against migration in only one direction.</li>\n</ul>\n\n<h3>Action by</h3>\n\n<p>Clinicians who manage and implant patients with IVC filters.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been sent to:</p>\n\n<ul>\n<li>Care Quality Commission (CQC) (Headquarters) for information</li>\n\n<li>HSC trusts in Northern Ireland (Chief Executives)</li>\n\n<li>NHS boards and trusts in Wales (Chief Executives)</li>\n\n<li>NHS boards in Scotland (Equipment Coordinators)</li>\n\n<li>NHS England area teams for information</li>\n\n<li>NHS trusts in England (Chief Executives)<br>\n</li>\n</ul>\n\n<h3>Onward distribution</h3>\n\n<p>Please bring this notice to the attention of relevant employees in your establishment. Below is a suggested list of recipients.</p>\n\n<p><span>Trusts</span><br>\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>Adult intensive care units</li>\n\n<li>Anti-coagulation nurse specialists</li>\n\n<li>Cardiac laboratory technicians</li>\n\n<li>Cardiologists</li>\n\n<li>Cardiology departments</li>\n\n<li>Cardiothoracic surgeons</li>\n\n<li>Clinical governance leads</li>\n\n<li>Consultant haematologists specialising in thromboprophylaxis</li>\n\n<li>Coronary care departments</li>\n\n<li>Intensive care nursing staff (adult)</li>\n\n<li>Intensive care units</li>\n\n<li>Medical directors</li>\n\n<li>Nursing executive directors</li>\n\n<li>Orthopaedic surgeons</li>\n\n<li>Purchasing managers</li>\n\n<li>Radiographer superintendents</li>\n\n<li>Radiographers</li>\n\n<li>Radiologists</li>\n\n<li>Radiology departments</li>\n\n<li>Radiology directors</li>\n\n<li>Risk managers</li>\n\n<li>Supplies departments</li>\n\n<li>Theatre managers</li>\n\n<li>Vascular surgeons</li>\n</ul>\n\n<h3>Independent distribution</h3>\n\n<p>Establishments registered with the Care Quality Commission (CQC) (England only)<br>\nThis alert should be read by:</p>\n\n<ul>\n<li>Hospitals in the independent sector</li>\n\n<li>Independent treatment centres</li>\n\n<li>Private medical practitioners</li>\n</ul>\n\n<p><span>Please note: </span>CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health&#8217;s Central Alerting System (CAS) by sending an email to: <a href=\"mailto:safetyalerts@dh.gsi.gov.uk\">safetyalerts@dh.gsi.gov.uk</a> and requesting this facility.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\tStephanie Armstrong<br>\nQuality/Regulatory Compliance Associate<br>\nJohnson &amp; Johnson Medical Limited, Pinewood Campus,<br>\nNinemile Ride, Wokingham, Berkshire, RG40 3EW<br>\nTel: 01344 871 103<br>\nEmail: <a href=\"mailto:sarmstr1@its.jnj.com\">sarmstr1@its.jnj.com</a>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\tIf you have any comments or feedback on this Medical Device Alert please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\">dts@mhra.gsi.gov.uk</a>.\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2014/001 </span>or <span>2013/010/010/081/003.</span></p>\n\n<p><span>Technical aspects</span><br>\nBayode Adisa or Alexander Mclaren<br>\nMedicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4, 151 Buckingham Palace Road<br>\nLondon&#160;<br>\nSW1W 9SZ<br>\nTel: 020 3080 7223 / 7292&#160;<br>\nFax: 020 8754 3965<br>\nEmail: <a href=\"mailto:bayode.adisa@mhra.gsi.gov.uk\">bayode.adisa@mhra.gsi.gov.uk</a> or <a href=\"mailto:alexander.mclaren@mhra.gsi.gov.uk\">alexander.mclaren@mhra.gsi.gov.uk</a></p>\n\n<p><span>Clinical aspects</span><br>\nMedicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4, 151 Buckingham Palace Road<br>\nLondon&#160;<br>\nSW1W 9SZ<br>\nTel: 020 3080 7032 / 7248<br>\nFax: 020 8754 3965<br>\nEmail: <a href=\"mailto:kayleigh.purdon@mhra.gsi.gov.uk\">kayleigh.purdon@mhra.gsi.gov.uk</a> or <a href=\"mailto:carol.lowry@mhra.gsi.gov.uk\">carol.lowry@mhra.gsi.gov.uk</a></p>\n\n<h3>How to report adverse incidents</h3>\n\n<p>Please report via our website:&#160;<a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\" added=\"null\">Reporting adverse incidents involving medical devices</a><br>\nFurther information about CAS can be found&#160;<a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\" added=\"null\">on the CAS website</a>&#160;(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.<br>\n<br>\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<p>Northern Ireland Adverse Incident Centre<br>\nHealth Estates Investment Group<br>\nRoom 17<br>\nAnnex 6<br>\nCastle Buildings, Stormont Estate<br>\nDundonald BT4 3SQ<br>\nTel: 02890 523 704<br>\nFax: 02890 523 900<br>\nEmail:&#160;<a href=\"mailto:NIAIC@dhsspsni.gov.uk\">NIAIC@dhsspsni.gov.uk</a></p>\n\n<h3>How to report adverse incidents in Northern Ireland</h3>\n\n<p>Please report directly to NIAIC, further information can be found on the&#160;<a href=\"http://www.dhsspsni.gov.uk/niaic\" added=\"null\">NIAIC website</a>&#160;(external link)<br>\nFurther information about SABS can be found&#160;<a href=\"http://sabs.dhsspsni.gov.uk/\" added=\"null\">on the SABS website</a>&#160;(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>All requests regarding return, replacement or modification of the devices mentioned in this alert should be directed to the relevant supplier or manufacturer.<br>\n<br>\nOther enquiries and adverse incident reports in Scotland should be addressed to:<br>\n<br>\nIncident Reporting and Investigation Centre<br>\nNHS National Services Scotland<br>\nGyle Square<br>\n1 South Gyle Crescent<br>\nEdinburgh EH12 9EB<br>\nTel: 0131 275 7575<br>\nFax: 0131 314 0722<br>\nEmail: <a href=\"mailto:nss.iric@nhs.net\">nss.iric@nhs.net</a></p>\n\n<p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\">Incident Reporting and Investigation Centre</a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:<br>\n<br>\nImproving Patient Safety Team<br>\nMedical Directorate<br>\nWelsh Government<br>\nCathays Park<br>\nCardiff CF10 3NQ</p>\n\n<p>Tel: 029 2082 5801<br>\nEmail:&#160;<a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\" added=\"null\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: OPTEASE\u00ae retrievable vena cava filter, manufactured by Cordis Corporation (MDA/2014/001)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": []
}